Journal of pain and symptom management
-
J Pain Symptom Manage · Feb 2021
Randomized Controlled TrialNephrologist views regarding cannabinoid use in advanced chronic kidney disease and dialysis: a survey.
The efficacy and safety of cannabinoids to treat symptoms in individuals with kidney disease is uncertain. ⋯ Nephrologists broadly support the use and study of cannabinoids for symptoms in patients with kidney disease.
-
J Pain Symptom Manage · Jan 2021
Randomized Controlled Trial Multicenter StudyThe effect of disclosing life expectancy information on patients' prognostic understanding: secondary outcomes from a multicenter randomized trial of a palliative chemotherapy educational intervention.
Many advanced patients with cancer have unrealistic prognostic expectations. ⋯ Offering LE information within a PC educational intervention had no effect on patients' prognostic expectations.
-
J Pain Symptom Manage · Jan 2021
Randomized Controlled TrialYokukansan for treatment of preoperative anxiety and prevention of postoperative delirium in cancer patients undergoing highly invasive surgery. J-SUPPORT 1605 (ProD Study): A randomized, double-blind, placebo-controlled trial.
No standard preventive or therapeutic methods have been established for preoperative anxiety and postoperative delirium in patients with cancer. ⋯ In patients with cancer undergoing highly invasive surgeries, yokukansan demonstrated no significant efficacy for the treatment of preoperative anxiety or the prevention of postoperative delirium. Yokukansan is already used in daily practice in Japan, but we should be careful with its future use.
-
J Pain Symptom Manage · Jan 2021
Randomized Controlled TrialHealth Information Preferences and Curability Beliefs Among Patients with Advanced Cancer.
Accurate prognostic understanding is associated with increased advance care planning, symptom control, and patient autonomy in oncology. The impact of prognostic understanding on patients' health information preferences (HIPs) and prognostic information preferences is unknown and has important implications for health care communication. ⋯ In the present study, prognostic understanding (i.e., curability beliefs) was not associated with HIPs. Therefore, oncology clinicians must individually and interatively evaluate patients' interest and preferences for receiving information. Future research should further clarify preferences for the framing and content of prognostic information from providers and improve the measurement of prognostic understanding to facilitate patient-centered end-of-life care.
-
J Pain Symptom Manage · Jan 2021
Randomized Controlled TrialA Population-based Mortality Follow-Back Survey Evaluating Good Death for Cancer and Non-cancer Patients: A Randomized Feasibility Study.
Evaluation of end-of-life care is a key element in quality improvement, and population-based mortality follow-back designs have been used in several countries. This design was adapted to evaluate a good death in Japan. ⋯ This study demonstrated the feasibility of conducting a population-based mortality follow-back survey using a randomized design. An attached pen with the questionnaire was effective in improving the response rate.